Powered by

Science 37® and Xperiome™ Partner to Increase the Efficiency and Speed of Rare Disease Studies for Patients and Providers; Using Science 37's decentralized clinical trial model, the partnership offers Xperiome's research-ready, rare disease patients more

Mar 11, 2021 - PR Newswire

PR Newswire

 Science 37, the industry leader in decentralized clinical trials, announced today a partnership with Xperiome, a global rare disease healthtech company. The partnership further strengthens Science 37's capabilities to bring research directly to patients, both by easing the patient burden and enabling treating physicians the opportunity to advance research as an investigator. Science 37 will leverage Xperiome's insights from Raremark, its data-driven knowledge bank powered by ...